Highlights del congreso eu

1. ESC 2011: Highlights
Dr. Edgar F. Hernández Paz, M.A.G.C, F.A.C.C.

2. ARISTOTLE
Apixaban vs. Warfarin in Patients with
Atrial Fibrillation
Apixaban vs. Warfarin in Patients with
Atrial Fibrillation

7. ASCOT-11
The Anglo-Scandinavian Cardiac Outcomes Trial Lipid
Lowering Arm (ASCOT-LLA) 11 Year Mortality Follow-Up
in the UK
The Anglo-Scandinavian Cardiac Outcomes Trial Lipid
Lowering Arm (ASCOT-LLA) 11 Year Mortality Follow-Up
in the UK

13. dal-VESSEL
Vascular Effects and Safety of Dalcetrapib in
Patients with or at Risk of Coronary Heart
Disease
Vascular Effects and Safety of Dalcetrapib in
Patients with or at Risk of Coronary Heart
Disease

17. *FMD: Flow Mediated Vasodilation

19. PURE
The Prospective Urban Rural
Epidemiologic Study
The Prospective Urban Rural
Epidemiologic Study

23. EMPHASIS-HF
The Effect of Eplerenone vs. Placebo on Cardiovascular Mortality
or Heart Failure Hospitalization in Subjects with NYHA Class II
Chronic Systolic Heart Failure: An Analysis of the “High Risk
Groups”
The Effect of Eplerenone vs. Placebo on Cardiovascular Mortality
or Heart Failure Hospitalization in Subjects with NYHA Class II
Chronic Systolic Heart Failure: An Analysis of the “High Risk
Groups”

24. N=1364
N=1373

29. SHIFT
Effect of Heart Rate Reduction with Ivabradine on Left
Ventricular Volume and Function: Results of the SHIFT
Echocardiographic Substudy
Effect of Heart Rate Reduction with Ivabradine on Left
Ventricular Volume and Function: Results of the SHIFT
Echocardiographic Substudy

35. CORP
Colchicine for Recurrent Pericarditis
Colchicine for Recurrent Pericarditis

39. PRODIGY
Prolonging Dual Antiplatelet Treatment After
Grading Stent-Induced Intimal Hyperplasia
Study
Prolonging Dual Antiplatelet Treatment After
Grading Stent-Induced Intimal Hyperplasia
Study

45. EXAMINATION
A Clinical Evaluation of Xience-V Stent in
Acute Myocardial Infarction
A Clinical Evaluation of Xience-V Stent in
Acute Myocardial Infarction

51. The Italian Elderly-ACS Randomised
Trial
Early Aggressive vs. Initially Conservative Strategy in Elderly
Patients witn non-ST elevation Acute Coronary Syndrome
Early Aggressive vs. Initially Conservative Strategy in Elderly
Patients witn non-ST elevation Acute Coronary Syndrome

58. ¡Gracias!